Multiply Labs
ActiveRobotic production capacity for the pharma manufacturing industry
About
The traditional manufacturing process for individualized drugs is extremely slow and expensive, because it is based on manual labor. At Multiply Labs, we believe that robotics is the only way to truly scale the production of individualized drugs - finally providing these life-saving therapies to the millions of patients who need them. We develop cloud-controlled modular robotic systems that manufacture individualized drugs, and we deploy these systems in the facilities of our pharma customers. This is pharma robotics as a service: we sell the robotic production capacity that our customers need to scale their next-gen individualized drugs.
Founders · 2
Related startups
The robotic cloud laboratory for the life sciences.
Robots that automate the everyday tasks of microbiologists.
